Scholar Rock Holding (SRRK) Cash from Operations (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Cash from Operations came in at 82101000.0 in Q1 2026, down 4.35% year-on-year from 85838963.64 in Q1 2025, and down 8.75% quarter-over-quarter from 75496000.0 in Q4 2025.

Scholar Rock Holding (SRRK) Cash from Operations (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Cash from Operations history runs 10 years deep, the most recent figure standing at 82101000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations fell 4.35% year-over-year to 82101000.0 in Q1 2026; TTM through Mar 2026 was 303461000.0, a 32.03% decrease from a year earlier, with the FY2025 full-year figure at 300035000.0, down 49.31% from the prior year.
  • Cash from Operations eased to 82101000.0 in Q1 2026 per SRRK's latest filing, from 75496000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 26483000.0 in Q3 2022 and bottomed at 82101000.0 in Q1 2026.
  • The 5-year median for Cash from Operations is 49196000.0 (2024), against an average of 50647352.94.
  • Across the five-year window, Cash from Operations gained 26.39% in 2022 and sank 62.54% in 2024, its largest moves.
  • Year by year, Cash from Operations stood at 28907000.0 in 2022, then slipped by 29.2% to 37349000.0 in 2023, then plunged by 32.57% to 49513000.0 in 2024, then sank by 52.48% to 75496000.0 in 2025, then declined by 8.75% to 82101000.0 in 2026.
  • Per Business Quant, the three latest SRRK Cash from Operations figures stand at 82101000.0 (Q1 2026), 75496000.0 (Q4 2025), and 68923000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.59 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 201.34 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.43 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.08 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.17 Mn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - -82.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -82.10 Mn
Mar 31, 2026 -82.10 Mn
Dec 31, 2025 -75.50 Mn
Dec 31, 2025 -75.50 Mn
Sep 30, 2025 -68.92 Mn
Sep 30, 2025 -68.92 Mn
Jun 30, 2025 -76.94 Mn
Jun 30, 2025 -76.94 Mn
Mar 31, 2025 -78.68 Mn
Mar 31, 2025 -78.68 Mn
Dec 31, 2024 -49.51 Mn
Dec 31, 2024 -49.51 Mn
Sep 30, 2024 -52.46 Mn
Sep 30, 2024 -52.46 Mn
Jun 30, 2024 -49.20 Mn
Jun 30, 2024 -49.20 Mn
Mar 31, 2024 -49.79 Mn
Mar 31, 2024 -49.79 Mn
Dec 31, 2023 -37.35 Mn
Dec 31, 2023 -37.35 Mn